ALFLUTOP®, conditioned as injectable solution, contains in 1 ml solution 10 mg bioactive concentrate (amino acids, low molecular mass peptides, mucopolysaccharides, trace elements: Na, K, Ca, Mg, Fe, Cu, Zn), maximum 5 mg/ml phenol as preservative.
ALFLUTOP® belongs to the group of chondroprotective products having anti-hyaluronidase, antiinflammatory and analgesic action:
inhibits hyaluronidase excess;
restores chondrocytes homeostasis in damaged tissues;
stimulates regenerative processes at cartilage level;
improves the synovial fluid and the afflicted cartilage quality;
stimulates superoxide dismutase;
inhibits occurrence of superoxide free radicals.
The clinical trials have proved the efficacy of the product ALFLUTOP® in degenerative articular rheumatism, post-traumatic pathology and abarticular rheumatism.
Advantages:
lack of major complications;
very well tolerated, even by the patients suffering from gastrointestinal, cardiovascular and metabolic diseases;
a favourable ratio of costs and clinical efficacy.
The clinical trials have also showed the therapeutical effect of ALFLUTOP® in the treatment of periarthritis, spondiloarthrosis, spinal disc injuries, ankylopoietic spondilitis, Reiter syndrome, rheumatoid polyarthritis
Therapy is for 21 days shot IM and can have the same results as Deca without the side effects...will tolerate a slin pin